EMA Authorised: DuoPlavin (clopidogrel;acetylsalicylic acid) — Sanofi Winthrop Industrie

View source ↗

Summary

DuoPlavin, a fixed-dose combination of clopidogrel and acetylsalicylic acid, has been authorised by EMA for acute coronary syndrome and myocardial infarction in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• DuoPlavin (clopidogrel; acetylsalicylic acid)

Snippet

Status: Authorised. Therapeutic area: Acute Coronary Syndrome;Myocardial Infarction. MAH: Sanofi Winthrop Industrie. Decision date: 27/04/2026